Response to: 'Impact of Janus kinase inhibitors on the risk of cardiovascular events in patients with rheumatoid arthritis: systematic review and meta-analysis of randomised controlled trials' by Lee and Song

Ann Rheum Dis. 2020 Oct;79(10):e123. doi: 10.1136/annrheumdis-2019-215841. Epub 2019 Jul 4.
No abstract available

Keywords: disease activity; rheumatoid arthritis; treatment.

Publication types

  • Comment

MeSH terms

  • Antirheumatic Agents* / adverse effects
  • Arthritis, Rheumatoid* / drug therapy
  • Cardiovascular Diseases* / chemically induced
  • Cardiovascular Diseases* / drug therapy
  • Cardiovascular Diseases* / epidemiology
  • Humans
  • Janus Kinase Inhibitors*

Substances

  • Antirheumatic Agents
  • Janus Kinase Inhibitors